The Motley Fool

NYSE:ZYME (Zymeworks Inc.)

$40.04 $-0.41 (-0.01) Thursday, February 27, 2020 at 2:59:16 p.m. Eastern Standard Time


Last updated Feb 27, 2020, 02:59:16pm EST
Current Price $40.04
Today's Change $-0.41 (-1%)
Close Price $40.45
Open Price $39.60
Bid $40.08
Ask $40.53
Day Range $37.80 - $40.96
Year Range $36.15 - $52.62
Volume 53,437
Average Volume 434,062
Market Cap $1,839,707,825.00
EPS (ttm) $-1.82

Related Articles

2 High-Growth Stocks That Could Explode in the Next Decade

Stocks like Aurora Cannabis Inc. (TSX:ACB)(NYSE:ACB) and Zymeworks Inc. (TSX:ZYME)(NYSE:ZYME) offer massive growth potential to investors with a long time horizon. More »

2 Stocks That Can Make You a TFSA Millionaire

Aspiring TFSA millionaires should target biotech stocks like Fennec Pharmaceuticals Inc. (TSX:FRX)(NASDAQ:FENC) and Zymeworks Inc. (TSX:ZYME)(NYSE:ZYME) in 2019. More »

Swing for the Fences and Buy This Growth Stock in April

Zymeworks (TSX:ZYME)(NYSE:ZYME) is set to spend more on its promising product candidates in 2019 and 2020. This is a stock to keep your eye... More »

2 Biopharma Stocks to Add to Your TFSA Today

Zymeworks Inc. (TSX:ZYME)(NYSE:ZYME) and HLS Therapeutics Inc. (TSX:HLS) offer the potential for huge growth over the next decade. More »

Stash This Growth Stock in Your TFSA Forever

Zymeworks Inc. (TSX:ZYME)(NYSE:ZYME) stock holds huge promise going forward on the back of its flagship products ZW25 and ZW49. More »

TFSA Investors: 2 Stocks That Can Provide Massive Growth Over the Next Decade

Zymeworks Inc. (TSX:ZYME)(NYSE:ZYME) and Jamieson Wellness Inc. (TSX:JWEL) are promising companies in two markets that are poised for huge growth over the next decade. More »

2 Growth Stocks for Young Investors to Hold Forever

Jamieson Wellness Inc. (TSX:JWEL) and Zymeworks Inc. (TSX:ZYME)(NYSE:ZYME) are both huge growth opportunities that young investors should be targeting. More »

These Growth Stocks Could Surge With a New NAFTA Deal

Pharmaceutical companies such as Zymeworks Inc. (TSX:ZYME)(NYSE:ZYME) could benefit from a new NAFTA deal that includes longer data protection for biologic drugs. More »

Sick of Cannabis Stocks? These 3 Biotech Stocks Offer Huge Growth Potential

Biotech stocks like Zymeworks (TSX:ZYME)(NYSE:ZYME) and others offer explosive long-term growth potential. More »

Young Investors: 3 Biotech Stocks That Can Electrify Your TFSA

Biotech stocks like Zymeworks Inc. (TSX:ZYME)(NYSE:ZYME) have soared in 2018 and have the potential to go much higher if flagship products break right. More »